Nicholas Theodosakis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nicholas Theodosakis has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
Arash Mostaghimi
Department of Dermatology, Brigham and Women’s Hospital, Boston, USA
9 shared publicationsKatherine Young
Harvard Medical School, Boston, USA
7 shared publicationsDavid H. Xiang
Harvard Med Sch, Boston, MA USA
6 shared publicationsKanika Kamal
Harvard Medical School, Boston, USA
6 shared publications- Goran Micevic
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut
5 shared publications Helen Ji
Department of Dermatology, Massachusetts General Hospital, Boston, USA
5 shared publications
Latest Publications
- 12 October 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 519
Hyperpigmentation is associated with increased risk of mood disorders: results from a national cohort study utilizing the TriNetX database
- 12 October 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 519
Hyperpigmentation is associated with increased risk of mood disorders: results from a national cohort study utilizing the TriNetX database
- Open Access
UV induces common cutaneous amyloid-like melanosomal protein aggregates
Misfolding of aggregation-prone proteins underpins diseases known as proteinopathies. One of these proteins, alpha-synuclein, is a component of aggregates in neurodegenerative conditions such as Parkinson’s disease. The melanosomal protein PMEL, which forms physiologic amyloid scaffold structures on which melanin is organized in melanosomes, similarly ectopically accumulates in the dermis in many forms of cutaneous hyperpigmentation. Here, we demonstrate in a wide range of common clinical pigmentary disorders, as well as in primary melanocyte and mouse models examined by molecular, proteomic, and electron microscopic tools, that melanocytic alpha-synuclein is a prominent component of intracellular protein aggregates bound to similar proteins as in Parkinson’s disease, as well as melanized extracellular protein deposits. Using the Real Time Quaking-Induced Conversion Assay (RT-QuIC), we demonstrate that UV induces misfolded melanosomal proteins to self-propagate, augmenting this pathology in prion-like fashion. CUT&RUN chromatin profiling and single-cell RNA-seq demonstrate that melanocytes utilize microphthalmia-associated transcription factor (MITF)-regulated autophagy to counteract protein aggregation, identifying aggregate removal as a core function of tanning. In contrast to extracellular aggregation, impaired intracellular aggregate removal contributes to melanocyte senescence, which conversely exacerbates chronic hypopigmentation and photoaging-related discoloration. These findings identify melanosomal proteinopathy as a common contributor to melanocyte dysfunction and suggest aggregate-focused management approaches.
Open AccessUV induces common cutaneous amyloid-like melanosomal protein aggregates
Misfolding of aggregation-prone proteins underpins diseases known as proteinopathies. One of these proteins, alpha-synuclein, is a component of aggregates in neurodegenerative conditions such as Parkinson’s disease. The melanosomal protein PMEL, which forms physiologic amyloid scaffold structures on which melanin is organized in melanosomes, similarly ectopically accumulates in the dermis in many forms of cutaneous hyperpigmentation. Here, we demonstrate in a wide range of common clinical pigmentary disorders, as well as in primary melanocyte and mouse models examined by molecular, proteomic, and electron microscopic tools, that melanocytic alpha-synuclein is a prominent component of intracellular protein aggregates bound to similar proteins as in Parkinson’s disease, as well as melanized extracellular protein deposits. Using the Real Time Quaking-Induced Conversion Assay (RT-QuIC), we demonstrate that UV induces misfolded melanosomal proteins to self-propagate, augmenting this pathology in prion-like fashion. CUT&RUN chromatin profiling and single-cell RNA-seq demonstrate that melanocytes utilize microphthalmia-associated transcription factor (MITF)-regulated autophagy to counteract protein aggregation, identifying aggregate removal as a core function of tanning. In contrast to extracellular aggregation, impaired intracellular aggregate removal contributes to melanocyte senescence, which conversely exacerbates chronic hypopigmentation and photoaging-related discoloration. These findings identify melanosomal proteinopathy as a common contributor to melanocyte dysfunction and suggest aggregate-focused management approaches.
- Open Access
- 1 October 2025
- Published by Elsevier in JAAD International
- Vol. 24, 95-97
Quantifying the risk of drug-associated skin hyperpigmentation relative to the general population: A national cohort study using TriNetX
- 1 October 2025
- Published by Elsevier in JAAD International
- Vol. 24, 95-97
Open AccessQuantifying the risk of drug-associated skin hyperpigmentation relative to the general population: A national cohort study using TriNetX
- 8 August 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (6) , 1211-1214
National trends in multi-modality keloid treatment claims from 2017-2020: an IBM Marketscan Study
- 8 August 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (6) , 1211-1214
National trends in multi-modality keloid treatment claims from 2017-2020: an IBM Marketscan Study
- Open Access
- 2 July 2024
- Published by Springer Nature in Dermatology and Therapy
- Vol. 14 (8) , 2109-2117
Association Between Natural Hair Color, Race, and Alopecia
Introduction Limited epidemiologic data has suggested direct associations between hair pigment, race, and incidence of alopecia areata (AA). Here, we examine the relationship between natural hair color, race, and the lifetime risk alopecia. Methods In this case–control study, we included UK Biobank patients of all races and self-reported hair color with diagnoses of AA, androgenetic alopecia (AGA), or scarring alopecia (SA). Multivariable logistic regression was used to detect differences in lifetime risk. Results Findings reveal a significantly increased risk of AA among individuals with black hair compared to dark brown hair (OR 1.71 [95% CI 1.22–2.38], p < 0.001). Those with red or blonde hair showed a decreased risk of AA (0.74 [0.56–0.97]; 0.62 [0.41–0.95], p < 0.05). No racial differences in AA prevalence were observed among individuals with black hair. Conclusions Darker hair colors may be associated with a higher risk of AA, lighter hair colors with a lower risk, and differences in hair color could contribute to previously noted racial variations in AA incidence, potentially influencing dermatologists’ perspectives on the disease’s epidemiology.
- 2 July 2024
- Published by Springer Nature in Dermatology and Therapy
- Vol. 14 (8) , 2109-2117
Open AccessAssociation Between Natural Hair Color, Race, and Alopecia
Introduction Limited epidemiologic data has suggested direct associations between hair pigment, race, and incidence of alopecia areata (AA). Here, we examine the relationship between natural hair color, race, and the lifetime risk alopecia. Methods In this case–control study, we included UK Biobank patients of all races and self-reported hair color with diagnoses of AA, androgenetic alopecia (AGA), or scarring alopecia (SA). Multivariable logistic regression was used to detect differences in lifetime risk. Results Findings reveal a significantly increased risk of AA among individuals with black hair compared to dark brown hair (OR 1.71 [95% CI 1.22–2.38], p < 0.001). Those with red or blonde hair showed a decreased risk of AA (0.74 [0.56–0.97]; 0.62 [0.41–0.95], p < 0.05). No racial differences in AA prevalence were observed among individuals with black hair. Conclusions Darker hair colors may be associated with a higher risk of AA, lighter hair colors with a lower risk, and differences in hair color could contribute to previously noted racial variations in AA incidence, potentially influencing dermatologists’ perspectives on the disease’s epidemiology.
- 17 May 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (5) , 1-3
Racial and ethnic differences in melasma treatment patterns: a multi-institution study
- 17 May 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (5) , 1-3
Racial and ethnic differences in melasma treatment patterns: a multi-institution study
- 8 May 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (3) , 539-541
A case-control study of racial differences in melasma risk factors and incidence in a diverse national United States population
- 8 May 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (3) , 539-541
A case-control study of racial differences in melasma risk factors and incidence in a diverse national United States population
- 19 April 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (2) , 356-359
Investigating price trends and cost-saving opportunities for prescription of topical calcineurin inhibitors using the Truven Marketscan Database
- 19 April 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 91 (2) , 356-359
Investigating price trends and cost-saving opportunities for prescription of topical calcineurin inhibitors using the Truven Marketscan Database
- 22 January 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (2) , 1-5
Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case–control study in the All of Us Research Program
Dermatologic diseases have a well-documented association with depression and anxiety, which are in turn often comorbid with alcohol use disorder (AUD). Nonethleess, the relationship between dermatologic disease and AUD, and the relative contribution of depression and anxiety, are poorly understood. Here, we utilize the National Insittutes of Health All of Us Research Program to investigate the association between inflammatory and pigmentary dermatologic diseases with AUD. Furthermore, we investigate whether comorbid depression and anxiety mediates this relationship. We employed a matched case–control model with multivariable logistic regression. We also employed a mediation analysis. We found an increased odds of AUD among patients with atopic dermatitis, acne/rosacea, hidradenitis suppurativa, psoriasis, and pigmentary disorders (vitiligo, melasma, and post-inflammatory hyperpigmentation). This was partially mediated by anxiety and depression, especially for diseases with a significant cosmetic component. Overall, these findings highlight the profound psychological and physical health effects that inflammatory and pigmentary disease can have on patients, both independently and in combination with comorbid psychiatric disease.
- 22 January 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (2) , 1-5
Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case–control study in the All of Us Research Program
Dermatologic diseases have a well-documented association with depression and anxiety, which are in turn often comorbid with alcohol use disorder (AUD). Nonethleess, the relationship between dermatologic disease and AUD, and the relative contribution of depression and anxiety, are poorly understood. Here, we utilize the National Insittutes of Health All of Us Research Program to investigate the association between inflammatory and pigmentary dermatologic diseases with AUD. Furthermore, we investigate whether comorbid depression and anxiety mediates this relationship. We employed a matched case–control model with multivariable logistic regression. We also employed a mediation analysis. We found an increased odds of AUD among patients with atopic dermatitis, acne/rosacea, hidradenitis suppurativa, psoriasis, and pigmentary disorders (vitiligo, melasma, and post-inflammatory hyperpigmentation). This was partially mediated by anxiety and depression, especially for diseases with a significant cosmetic component. Overall, these findings highlight the profound psychological and physical health effects that inflammatory and pigmentary disease can have on patients, both independently and in combination with comorbid psychiatric disease.